DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

71.89 1.32 (1.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $71.89 1.87%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.51
Previous Close $70.57
Daily Range $71.26 - $72.22
52-Week Range $61.75 - $82.68
Market Cap $90.8B
P/E Ratio 34.59
Dividend (Yield) $1.80 (4.0%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/15/14
Volume 4,827,756
Average Daily Volume 1,586,511
Current FY EPS $4.35

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

Bristol-Myers Squibb Co.'s Fourth Quarter Earnings Warn of a Tough Year Ahead

Bristol-Myers Squibb Co. reported its fourth quarter earnings Tuesday morning. Here's what investors need to know.

Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog

3 Health Care Stocks Pushing The Sector Higher

Benzinga's Volume Movers

Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come

Pfizer Inc. reported its fourth-quarter earnings before the bell this morning. Here's what investors need to know going forward.

Pre-Market Activity Shows Heavy Volume And Movement For AstraZeneca (AZN)

Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead

3 Motley Fool contributors offer up suggestions on what they believe Pfizer should acquire.

Is A Generic Nexium Purple Pill For You?

AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog

A New Price Estimate Now That Afrezza Is Launching

See More AZN News...

AZN's Top Competitors

AZN $71.89 (1.87%)
Current stock: AZN
NVS $98.93 (2.53%)
Current stock: NVS
RHHBY $35.70 (0.63%)
Current stock: RHHBY
PFE $32.60 (-0.61%)
Current stock: PFE